Trials that use: P-values
New to this method? Read the tutorial →
20,601 results
- Ixabepilone to Treat Cervical Cancer: Complete Statistical AnalysisIndependent statistical analysis of Ixabepilone to Treat Cervical Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00924066).
- Ixazomib and Dexamethasone Versus Ixazomib, Dexamethasone and Lenalidomide, Randomized With NFKB2 Rearrangement: Complete Statistical AnalysisIndependent statistical analysis of Ixazomib and Dexamethasone Versus Ixazomib, Dexamethasone and Lenalidomide, Randomized With NFKB2 Rearrangement: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Ixazomib and Rituximab in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma: Complete Statistical AnalysisIndependent statistical analysis of Ixazomib and Rituximab in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Ixazomib Citrate in Treating Patients With Relapsed Multiple Myeloma That Is Not Refractory to Bortezomib: Complete Statistical AnalysisIndependent statistical analysis of Ixazomib Citrate in Treating Patients With Relapsed Multiple Myeloma That Is Not Refractory to Bortezomib: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Ixazomib Citrate, Pomalidomide, Dexamethasone, Stem Cell Transplant in Treating Relapsed or Refractory Multiple Myeloma: Complete Statistical AnalysisIndependent statistical analysis of Ixazomib Citrate, Pomalidomide, Dexamethasone, Stem Cell Transplant in Treating Relapsed or Refractory Multiple Myeloma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Ixazomib Plus Pomalidomide and Dexamethasone in Treating Patients With Relapsed or Relapsed/Refractory Multiple Myeloma: Complete Statistical AnalysisIndependent statistical analysis of Ixazomib Plus Pomalidomide and Dexamethasone in Treating Patients With Relapsed or Relapsed/Refractory Multiple Myeloma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Ixazomib With Cyclophosphamide and Dexamethasone in Patients With Previously Untreated Symptomatic Multiple Myeloma or Light Chain Amyloidosis: Complete Statistical AnalysisIndependent statistical analysis of Ixazomib With Cyclophosphamide and Dexamethasone in Patients With Previously Untreated Symptomatic Multiple Myeloma or Light Chain Amyloidosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- IXORA-RIndependent statistical analysis of A Study of Ixekizumab (LY2439821) Compared to Guselkumab in Participants With Moderate-to-Severe Plaque Psoriasis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- IXTENDIndependent statistical analysis of Randomized Study Evaluating Ixabepilone Plus Capecitabine or Docetaxel Plus Capecitabine in Metastatic Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- J-MINDIndependent statistical analysis of To Assess the Safety and Tolerability of Tafasitamab Alone or in Combination With Other Drugs in Japanese Participants With Non-Hodgkins Lymphoma (NHL): primary endpoint results, effect estimate with…
- J-TARGET,Japanese Telmisartan Study for Antihypertensive Good Effect in Long Term Observation: Complete Statistical AnalysisIndependent statistical analysis of J-TARGET,Japanese Telmisartan Study for Antihypertensive Good Effect in Long Term Observation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- JACOBIndependent statistical analysis of A Study of Pertuzumab in Combination With Trastuzumab and Chemotherapy in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Gastroesophageal Junction or Gastric Cancer: primary endpoint…
- JADE MOAIndependent statistical analysis of Study Evaluating the Mechanism of Action of PF-04965842 Monotherapy for Moderate-to-severe Atopic Dermatitis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- JADE Mono-1Independent statistical analysis of Study to Evaluate Efficacy and Safety of PF-04965842 in Subjects Aged 12 Years And Older With Moderate to Severe Atopic Dermatitis: primary endpoint results, effect estimate with confidence…
- JADE Mono-2Independent statistical analysis of Study Evaluating Efficacy and Safety of PF-04965842 in Subjects Aged 12 Years And Older With Moderate to Severe Atopic Dermatitis: primary endpoint results, effect estimate with confidence interval,…
- JADE TEENIndependent statistical analysis of JAK1 Inhibitor With Medicated Topical Therapy in Adolescents With Atopic Dermatitis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- JAK Inhibitor Before Donor Stem Cell Transplant in Treating Patients With Primary or Secondary Myelofibrosis: Complete Statistical AnalysisIndependent statistical analysis of JAK Inhibitor Before Donor Stem Cell Transplant in Treating Patients With Primary or Secondary Myelofibrosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- JAKARTAIndependent statistical analysis of Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- JakStat2Independent statistical analysis of Topical Interferon Gamma for Macular Edema Secondary to Uveitis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01376362).
- Janus Kinase Inhibition in Granuloma Annulare: Complete Statistical AnalysisIndependent statistical analysis of Janus Kinase Inhibition in Granuloma Annulare: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05650736).
- Japanese AMLIndependent statistical analysis of Entospletinib (ENTO) as Monotherapy and in Combination With Chemotherapy in Japanese Adults: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Japanese IP-TN Trial: Complete Statistical AnalysisIndependent statistical analysis of Japanese IP-TN Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02831569).
- Japanese Phase 1 Trial of Sym004 in Solid Tumors: Complete Statistical AnalysisIndependent statistical analysis of Japanese Phase 1 Trial of Sym004 in Solid Tumors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01955473).
- Japanese Phase II Study of SB-497115-GR in Hepatitis C Virus Infected Patients: Complete Statistical AnalysisIndependent statistical analysis of Japanese Phase II Study of SB-497115-GR in Hepatitis C Virus Infected Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Japanese Study of Ipilimumab Administered in Combination With Paclitaxel/Carboplatin in Patients With Nonsmall-cell Lung Cancer: Complete Statistical AnalysisIndependent statistical analysis of Japanese Study of Ipilimumab Administered in Combination With Paclitaxel/Carboplatin in Patients With Nonsmall-cell Lung Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- JARDIANCE® Post Marketing Surveillance in Korean Patients With Chronic Kidney Disease (CKD): Complete Statistical AnalysisIndependent statistical analysis of JARDIANCE® Post Marketing Surveillance in Korean Patients With Chronic Kidney Disease (CKD): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- JAVAIndependent statistical analysis of Purple Grape Juice in Improving Vascular Health in Childhood Cancer Survivors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- JAVELIN Bladder 100A detailed statistical analysis of the randomized phase 3 JAVELIN Bladder 100 trial of avelumab plus best supportive care versus best supportive care in patients with urothelial cancer, including trial design, time-to-event…
- Javelin BRCA/ATM: Avelumab Plus Talazoparib in Patients With BRCA or ATM Mutant Solid Tumors: Complete Statistical AnalysisIndependent statistical analysis of Javelin BRCA/ATM: Avelumab Plus Talazoparib in Patients With BRCA or ATM Mutant Solid Tumors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- JAVELIN Ovarian 100Independent statistical analysis of JAVELIN Ovarian 100, the phase 3 trial of avelumab-based strategies in previously untreated epithelial ovarian cancer, including progression-free survival, overall survival, statistical methodology, safety, and interpretation.
- Javelin Parp Medley: Avelumab Plus Talazoparib In Locally Advanced Or Metastatic Solid Tumors: Complete Statistical AnalysisIndependent statistical analysis of Javelin Parp Medley: Avelumab Plus Talazoparib In Locally Advanced Or Metastatic Solid Tumors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- JAWLINEIndependent statistical analysis of Sequential Treatment With BELKYRA® Then Juvéderm® VOLUMA™ With Lidocaine for Overall Improvement in Jawline Contour: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- JENIndependent statistical analysis of Probiotics and Health-related Quality of Life in Individuals With Seasonal Allergies: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- JENAVALVE AS EFS TRIAL: Pericardial TAVR Aortic Stenosis Study: Complete Statistical AnalysisIndependent statistical analysis of JENAVALVE AS EFS TRIAL: Pericardial TAVR Aortic Stenosis Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02732691).
- JET-ISRIndependent statistical analysis of JetStream Atherectomy for the Treatment of In-stent Restenosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02730234).
- JETiIndependent statistical analysis of JETi Lower Extremity Arterial Thrombosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04370691).
- Jewel Electrophysiology (EP) Lab Study: Complete Statistical AnalysisIndependent statistical analysis of Jewel Electrophysiology (EP) Lab Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05490459).
- JintronixIndependent statistical analysis of A New Adaptive Physical Activity Technology in Older Adults: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02467491).
- JiVitA-3Independent statistical analysis of Antenatal Micronutrient Supplementation and Infant Survival: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00860470).
- JNJ-40346527 in Treating Participants With Relapsed or Refractory Acute Myeloid Leukemia: Complete Statistical AnalysisIndependent statistical analysis of JNJ-40346527 in Treating Participants With Relapsed or Refractory Acute Myeloid Leukemia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- JOTIndependent statistical analysis of Journey of Transformation Curriculum for Native American Adolescents: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05274217).
- JOTROL PK, Safety, and Food Effect Assessment: Complete Statistical AnalysisIndependent statistical analysis of JOTROL PK, Safety, and Food Effect Assessment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04668274).
- Journeys to Wellness: A Transplant Candidate Study: Complete Statistical AnalysisIndependent statistical analysis of Journeys to Wellness: A Transplant Candidate Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01254214).
- Joyful Parenting Pilot Project RCT Study: Complete Statistical AnalysisIndependent statistical analysis of Joyful Parenting Pilot Project RCT Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03282071).
- JPN ATO OLEIndependent statistical analysis of A Study Evaluating Oral Atogepant for the Prevention of Migraine in Japanese Participants With Chronic or Episodic Migraine: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- JPSIndependent statistical analysis of Observational Study on JuniOrtho Plating System for Deformities and Fractures Treatment in Lower Limb: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Jugular Venous Flow Healthy Volunteers: Complete Statistical AnalysisIndependent statistical analysis of Jugular Venous Flow Healthy Volunteers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02002494).
- Jump StartIndependent statistical analysis of Jump Start Shared Medical Appointments for Diabetes With Weight Management: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01973972).
- Junctional AV Ablation in CRT-D: JAVA-CRT: Complete Statistical AnalysisIndependent statistical analysis of Junctional AV Ablation in CRT-D: JAVA-CRT: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02946853).
- JUNGLEIndependent statistical analysis of Dolutegravir/Rilpivirine, Antiretroviral Efficacy Study Using Real-world Data in Subjects With Human Immunodeficiency Virus (HIV)-1: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…